Literature DB >> 20659085

Alloimmune activation enhances innate tissue inflammation/injury in a mouse model of liver ischemia/reperfusion injury.

X Shen1, F Reng, F Gao, Y Uchida, R W Busuttil, J W Kupiec-Weglinski, Y Zhai.   

Abstract

The deleterious sensitization to donor MHC Ags represents one of the most challenging problems in clinical organ transplantation. Although the role of effector/memory T cells in the rejection cascade has been extensively studied, it remains unknown whether and how these 'Ag-specific' cells influence host innate immunity, such as tissue inflammation associated with ischemia and reperfusion injury (IRI). In this study, we analyzed how allogeneic skin transplant (Tx) affected the sequel of host's own liver damage induced by partial warm ischemia and reperfusion. Our data clearly showed that allo-Tx recipients had increased inflammatory response against IR insult in their native livers, as evidenced by significantly more severe hepatocelluar damage, compared with syngeneic Tx recipient controls, and determined by serum ALT levels, liver histology (Suzuki's score) and intrahepatic proinflammatory gene inductions (TNF-alpha, IL-1beta and CXCL10). The CD4 T cells, but neither CD8 nor NK cells, mediated the detrimental effect of allo-Ag sensitization in liver IRI. Furthermore, CD154, but not IFN-gamma, was the key mechanism in allo-Tx recipients to facilitate IR-triggered liver damage. These results provide new evidence that alloreactive CD4 T cells are capable of enhancing innate tissue inflammation and organ injury via an Ag-nonspecific CD154-dependent but IFN-gamma independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659085      PMCID: PMC3655759          DOI: 10.1111/j.1600-6143.2010.03205.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  51 in total

1.  Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.

Authors:  Yuan Zhai; Lingzhong Meng; Feng Gao; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

2.  B cell deficiency confers protection from renal ischemia reperfusion injury.

Authors:  Melissa J Burne-Taney; Dolores B Ascon; Frank Daniels; Lorraine Racusen; William Baldwin; Hamid Rabb
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

Review 3.  Effects of initial ischemia/reperfusion injury on the transplanted kidney.

Authors:  N L Tilney; R D Guttmann
Journal:  Transplantation       Date:  1997-10-15       Impact factor: 4.939

Review 4.  The T cell as a bridge between innate and adaptive immune systems: implications for the kidney.

Authors:  Hamid Rabb
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

5.  CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury, and its blockade facilitates and depends on heme oxygenase-1 mediated cytoprotection.

Authors:  Xiu-Da Shen; Bibo Ke; Yuan Zhai; Farin Amersi; Feng Gao; Dean M Anselmo; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Transplantation       Date:  2002-08-15       Impact factor: 4.939

6.  Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice.

Authors:  Jun-ichi Oyama; Charles Blais; Xiaoli Liu; Minying Pu; Lester Kobzik; Ralph A Kelly; Todd Bourcier
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

7.  Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection.

Authors:  Xiu-Da Shen; Bibo Ke; Yuan Zhai; Feng Gao; Dean Anselmo; Charles R Lassman; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

8.  Recipient T cells mediate reperfusion injury after lung transplantation in the rat.

Authors:  Marc de Perrot; Kevin Young; Yumiko Imai; Mingyao Liu; Thomas K Waddell; Stefan Fischer; Li Zhang; Shaf Keshavjee
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

9.  Toll-like receptor-4 and allograft responses.

Authors:  Benjamin Samstein; Geoffrey B Johnson; Jeffrey L Platt
Journal:  Transplantation       Date:  2004-02-15       Impact factor: 4.939

10.  CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.

Authors:  Kevin J Maloy; Laurence Salaun; Rachel Cahill; Gordon Dougan; Nigel J Saunders; Fiona Powrie
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

View more
  10 in total

1.  Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells.

Authors:  W H Kitchens; D Haridas; M E Wagener; M Song; A D Kirk; C P Larsen; M L Ford
Journal:  Am J Transplant       Date:  2011-09-22       Impact factor: 8.086

2.  Sotrastaurin, a protein kinase C inhibitor, ameliorates ischemia and reperfusion injury in rat orthotopic liver transplantation.

Authors:  N Kamo; X-D Shen; B Ke; R W Busuttil; J W Kupiec-Weglinski
Journal:  Am J Transplant       Date:  2011-08-30       Impact factor: 8.086

3.  Ag-specific CD4 T cells promote innate immune responses in liver ischemia reperfusion injury.

Authors:  Jianhua Rao; Feng Cheng; Shikun Yang; Yuan Zhai; Ling Lu
Journal:  Cell Mol Immunol       Date:  2018-06-15       Impact factor: 11.530

Review 4.  Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation.

Authors:  Y Zhai; R W Busuttil; J W Kupiec-Weglinski
Journal:  Am J Transplant       Date:  2011-06-10       Impact factor: 8.086

5.  Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7.

Authors:  Andrea Vergani; Sara Tezza; Francesca D'Addio; Carmen Fotino; Kaifeng Liu; Monika Niewczas; Roberto Bassi; R Damaris Molano; Sonja Kleffel; Alessandra Petrelli; Antonio Soleti; Enrico Ammirati; Maria Frigerio; Gary Visner; Fabio Grassi; Maria E Ferrero; Domenico Corradi; Reza Abdi; Camillo Ricordi; Mohamed H Sayegh; Antonello Pileggi; Paolo Fiorina
Journal:  Circulation       Date:  2012-12-18       Impact factor: 29.690

Review 6.  T cells in organ ischemia reperfusion injury.

Authors:  Jianhua Rao; Ling Lu; Yuan Zhai
Journal:  Curr Opin Organ Transplant       Date:  2014-04       Impact factor: 2.640

Review 7.  Natural Killer T Cells in Liver Ischemia-Reperfusion Injury.

Authors:  Michael A Zimmerman; Alicia Martin; Jennifer Yee; Jennifer Schiller; Johnny C Hong
Journal:  J Clin Med       Date:  2017-04-01       Impact factor: 4.241

8.  E3 ubiquitin ligase ring finger protein 5 protects against hepatic ischemia reperfusion injury by mediating phosphoglycerate mutase family member 5 ubiquitination.

Authors:  Ming-Jie Ding; Hao-Ran Fang; Jia-Kai Zhang; Ji-Hua Shi; Xiao Yu; Pei-Hao Wen; Zhi-Hui Wang; Sheng-Li Cao; Yi Zhang; Xiao-Yi Shi; Hua-Peng Zhang; Yu-Ting He; Bing Yan; Hong-Wei Tang; Dan-Feng Guo; Jie Gao; Zhen Liu; Li Zhang; Shui-Jun Zhang; Xiao-Jing Zhang; Wen-Zhi Guo
Journal:  Hepatology       Date:  2022-01-23       Impact factor: 17.298

9.  Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection.

Authors:  Andrea Vergani; Carmen Fotino; Francesca D'Addio; Sara Tezza; Michele Podetta; Francesca Gatti; Melissa Chin; Roberto Bassi; Ruth D Molano; Domenico Corradi; Rita Gatti; Maria E Ferrero; Antonio Secchi; Fabio Grassi; Camillo Ricordi; Mohamed H Sayegh; Paola Maffi; Antonello Pileggi; Paolo Fiorina
Journal:  Diabetes       Date:  2013-01-11       Impact factor: 9.461

10.  CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells.

Authors:  Ivana R Ferrer; Maylene E Wagener; Mingqing Song; Mandy L Ford
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.